albuterol has been researched along with Becker Muscular Dystrophy in 4 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen boys with Duchenne or Becker muscular dystrophy, 6 to 11 years old, completed two treatment periods (albuterol and placebo), 12 weeks each, separated by a 12-week washout period." | 9.13 | Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. ( Fowler, EG; Graves, M; Skura, CL; Spencer, MJ; Wetzel, GT, 2008) |
| "Fourteen boys with Duchenne or Becker muscular dystrophy, 6 to 11 years old, completed two treatment periods (albuterol and placebo), 12 weeks each, separated by a 12-week washout period." | 5.13 | Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. ( Fowler, EG; Graves, M; Skura, CL; Spencer, MJ; Wetzel, GT, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, EG | 2 |
| Graves, MC | 1 |
| Wetzel, GT | 2 |
| Spencer, MJ | 2 |
| Restrepo, S | 1 |
| Skura, CL | 1 |
| Graves, M | 1 |
| Lynch, GS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect on Body Composition With Albuterol and Caffeine Versus Placebo in Adolescents: A Pilot Study[NCT02740660] | 12 participants (Actual) | Interventional | 2016-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
DXA Scan of obese adolescents (NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 0.97 |
| Placebo | -0.21 |
DXA Scan of obese adolescents (NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 1.34 |
| Placebo | 0.88 |
(NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 2.57 |
| Placebo | 1.05 |
(NCT02740660)
Timeframe: Week 2, Week 4, Week 6, Week 8
| Intervention | Participants (Count of Participants) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 5 |
| Placebo | 2 |
1 review available for albuterol and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Therapies for improving muscle function in neuromuscular disorders.
Topics: Adjuvants, Immunologic; Adrenergic beta-Agonists; Albuterol; Aminoglycosides; Animals; Anti-Bacteria | 2001 |
2 trials available for albuterol and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Pilot trial of albuterol in Duchenne and Becker muscular dystrophy.
Topics: Adrenergic beta-Agonists; Albuterol; Child; Cross-Over Studies; Double-Blind Method; Dystrophin; Fol | 2004 |
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy.
Topics: Adrenergic beta-Agonists; Albuterol; Body Mass Index; Child; Double-Blind Method; Humans; Male; Musc | 2008 |
1 other study available for albuterol and Becker Muscular Dystrophy
| Article | Year |
|---|---|
New treatment alternatives for Duchenne and Becker muscular dystrophy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool; Clinical Trials | 2004 |